SEARCH

SEARCH BY CITATION

References

  • 1
    Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J. Gastroenterol. 2006; 12: 480712.
  • 2
    Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 150417.
  • 3
    Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J. Gastroenterol. 2008; 103: 316782.
    Direct Link:
  • 4
    Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am. J. Gastroenterol. 2009; 104: 21009.
  • 5
    Probert CS, Jayanthi V, Pinder D. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 68793.
  • 6
    Probert CS, Jayanthi V, Hughes AO, Thompson JR, Wicks AC, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 1993; 34: 154751.
  • 7
    Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q. J. Med. 1992; 82: 12538.
  • 8
    Molinie F, Gower-Rousseau C, Yzet T et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988–1999). Gut 2004; 53: 8438.
  • 9
    Wilson J, Hair C, Knight R et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm. Bowel Dis. 2010; 16: 15506.
  • 10
    Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm. Bowel Dis. 2006; 12: 93643.
  • 11
    Kappelman MD, Rifas-Shiman SL, Kleinman K et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol. 2007; 5: 14249.
  • 12
    Bernstein CN, Wajda A, Svenson LW. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 2006; 101: 155968.
    Direct Link:
  • 13
    Yang SK, Yun S, Kim JH et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm. Bowel Dis. 2008; 14: 5429.
  • 14
    Higashi A, Watanabe Y, Ozasa K, Hayashi K, Aoike A, Kawai K. Prevalence and mortality of ulcerative colitis and Crohn's disease in Japan. Gastroenterol. Jpn. 1988; 23: 5216.
  • 15
    Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis. Colon Rectum 2000; 43: S8593.
  • 16
    Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J. Gastroenterol. 2009; 44: 65965.
  • 17
    Sung JJ, Kamm MA, Marteau P. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey. J. Gastroenterol. Hepatol. 2010; 25: 18393.
  • 18
    Ouyang Q, Tandon R, Goh KL, Ooi CJ, Ogata H, Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr. Opin. Gastroenterol. 2005; 21: 40813.
  • 19
    Ooi CJ, Fock KM, Makharia GK et al. The Asia-Pacific consensus on ulcerative colitis. J. Gastroenterol. Hepatol. 2010; 25: 45368.
  • 20
    Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang S-K. Diagnostic guideline of Crohn's disease. Korean J. Gastroenterol. 2009; 53: 16176.
  • 21
    Choi CH, Jung SA, Lee BI, Lee KM, Kim JS, Han DS. Diagnostic guideline of ulcerative colitis. Korean J. Gastroenterol. 2009; 53: 14560.
  • 22
    Bernstein CN, Fried M, Krabshuis JH et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis. 2010; 16: 11224.
  • 23
    Sung JJ, Hsu RK, Chan FK. Crohn's disease in the Chinese population. An experience from Hong Kong. Dis. Colon Rectum 1994; 37: 13079.
  • 24
    Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm. Bowel Dis. 2004; 10: 64651.
  • 25
    Lok KH, Hung HG, Ng CH et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J. Gastroenterol. Hepatol. 2008; 23: 40610.
  • 26
    Chow DK, Leong RW, Tsoi KK et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am. J. Gastroenterol. 2009; 104: 64754.
  • 27
    Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55 years of research. J. Dig. Dis. 2010; 11: 1616.
  • 28
    Morita N, Toki S, Hirohashi T. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J. Gastroenterol. 1995; 30: 14.
  • 29
    Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J. Gastroenterol. 1995; 30 (Suppl. 8): 58.
  • 30
    Shin DH, Sinn DH, Kim YH et al. Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig. Dis. Sci. 2011; 56: 11549.
  • 31
    Lee YM, Fock K, See SJ. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J. Gastroenterol. Hepatol. 2000; 15: 6225.
  • 32
    Tan YM, Goh KL. Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients. World J. Gastroenterol. 2005; 11: 585962.
  • 33
    Thia KT, Luman W, Jin OC. Crohn's disease runs a more aggressive course in young Asian patients. Inflamm. Bowel Dis. 2006; 12: 5761.
  • 34
    Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52: 158790.
  • 35
    Niriella MA, De Silva AP, Dayaratne AH et al. Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol. 2010; 10: 32.
  • 36
    Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991–1994). Am. J. Gastroenterol. 1999; 94: 291822.
  • 37
    Jayanthi V, Probert CS, Pollock DJ, Baithun SI, Rampton DS, Mayberry JF. Low incidence of ulcerative colitis and proctitis in Bangladeshi migrants in Britain. Digestion 1992; 52: 3442.
  • 38
    Probert CS, Jayanthi V, Pollock DJ, Baithun SI, Mayberry JF, Rampton DS. Crohn's disease in Bangladeshis and Europeans in Britain: an epidemiological comparison in Tower Hamlets. Postgrad. Med. J. 1992; 68: 91420.
  • 39
    Tsironi E, Feakins RM, Probert CS. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am. J. Gastroenterol. 2004; 99: 174955.
  • 40
    Fellows IW, Mayberry JF, Holmes GK. Crohn's disease in West Indians. Am. J. Gastroenterol. 1988; 83: 7525.
  • 41
    Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992; 102: 19408.
  • 42
    Pinsk V, Lemberg DA, Grewal K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am. J. Gastroenterol. 2007; 102: 107783.
    Direct Link:
  • 43
    Li X, Sundquist J, Hemminki K, Sundquist K. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm. Bowel Dis. 2011; 17: 178491.
  • 44
    Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57: 118591.
  • 45
    Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J. Dig. Dis. 2010; 11: 7682.
  • 46
    Kim BJ, Song SM, Kim KM et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig. Dis. Sci. 2010; 55: 198995.
  • 47
    Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm. Bowel Dis. 2001; 7: 26070.
  • 48
    Kang J, Shin DH, Lee JH, Bang S, Kim DI. Rapid increase in the prevalence of inflammatory bowel disease in candidates for the military service born after 1988 in Korea. Inflamm. Bowel Dis. 2011; 17: E22.
  • 49
    Tan A, Wee A, Quak SH. Chronic inflammatory bowel disease in Singapore children. J. Singapore Paediatr. Soc. 1992; 34: 20913.
  • 50
    Treepongkaruna S, Pienvichit P, Sornmayura P. Inflammatory bowel disease in Thai children: presentations and outcomes of treatment. Asian Pac. J. Allergy Immunol. 2006; 24: 739.
  • 51
    Avinash B, Dutta AK, Chacko A. Pediatric inflammatory bowel disease in South India. Indian Pediatr. 2009; 46: 63940.
  • 52
    Ishige T, Tomomasa T, Takebayashi T et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J. Gastroenterol. 2010; 45: 91117.
  • 53
    Hilmi I, Tan YM, Goh KL. Crohn's disease in adults: observations in a multiracial Asian population. World J. Gastroenterol. 2006; 12: 14358.
  • 54
    Probert CS, Jayanthi V, Mayberry JF. Inflammatory bowel disease in Indian migrants in Fiji. Digestion 1991; 50: 824.
  • 55
    Ling KL, Ooi CJ, Luman W. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J. Clin. Gastroenterol. 2002; 35: 1448.
  • 56
    Hilmi I, Singh R, Ganesananthan S et al. Demography and clinical course of ulcerative colitis in a multiracial Asian population: a nationwide study from Malaysia. J. Dig. Dis. 2009; 10: 1520.
  • 57
    Benfield GF, Montgomery RD, Asquith P. Ulcerative colitis in Asian immigrants. Postgrad. Med. J. 1987; 63: 62935.
  • 58
    Rashid ST, Bharucha S, Jamallulail SI et al. Inflammatory bowel disease in the South Asian population of Northwest England. Am. J. Gastroenterol. 2008; 103: 2423. author reply 3–4.
  • 59
    Mangat BK, Evaschen C, Lee T, Yoshida EM, Salh B. Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia. Can. J. Gastroenterol. 2011; 25: 737.
  • 60
    Freeman HJ. Inflammatory bowel diseases in Indo-Canadians with and without antineutrophil cytoplasmic autoantibodies. Can. J. Gastroenterol. 2000; 14: 216.
  • 61
    Lowe AM, Roy PO, B-Poulin M et al. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm. Bowel Dis. 2009; 15: 42935.
  • 62
    Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 2005; 100: 225461.
    Direct Link:
  • 63
    Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm. Bowel Dis. 2008; 14: 1319.
  • 64
    Flasar MH, Quezada S, Bijpuria P, Cross RK. Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study. Dig. Dis. Sci. 2008; 53: 275460.
  • 65
    Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am. J. Gastroenterol. 2010; 105: 22028.
  • 66
    Nguyen GC, Bayless TM, Powe NR. Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection. Inflamm. Bowel Dis. 2007; 13: 140816.
  • 67
    Sewell JL, Yee HF Jr, Inadomi JM. Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 2010; 16: 2047.
  • 68
    Vind I, Riis L, Jess T et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen city and county, 2003–2005: a population-based study from the Danish Crohn colitis database. Am. J. Gastroenterol. 2006; 101: 127482.
  • 69
    Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand. J. Gastroenterol. 1992; 27: 60914.
  • 70
    Jiang L, Xia B, Li J et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm. Bowel Dis. 2006; 12: 21217.
  • 71
    Luo CH, Wexner SD, Liu QS, Li L, Weiss E, Zhao RH. The differences between American and Chinese patients with Crohn's disease. Colorectal Dis. 2011; 13: 16670.
  • 72
    Song XM, Gao X, Li MZ et al. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort. Dis. Colon Rectum 2011; 54: 114754.
  • 73
    Cao Q, Si JM, Gao M, Zhou G, Hu WL, Li JH. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China. Chin. Med. J. 2005; 118: 74752.
  • 74
    Group A. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J. Gastroenterol. Hepatol. 2006; 21: 100915.
  • 75
    Chow DK, Leong RW, Lai LH et al. Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm. Bowel Dis. 2008; 14: 53641.
  • 76
    Oriuchi T, Hiwatashi N, Kinouchi Y. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J. Gastroenterol. 2003; 38: 94253.
  • 77
    Ye BD, Yang S-K Cho YK et al. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand. J. Gastroenterol. 2010; 45: 117885.
  • 78
    Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig. Dis. Sci. 2009; 54: 1099107.
  • 79
    Subasinghe D, Nawarathna NM, Samarasekera DN. Disease characteristics of Inflammatory Bowel Disease (IBD): findings from a Tertiary Care Centre in South Asia. J. Gastrointest. Surg. 2011; 15: 15627.
  • 80
    Fujimoto T, Kato J, Nasu J. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur. J. Gastroenterol. Hepatol. 2007; 19: 22935.
  • 81
    Wang Y, Ouyang Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J. Gastroenterol. Hepatol. 2007; 22: 14505.
  • 82
    Ray G. Inflammatory bowel disease in India—changing paradigms. Int. J. Colorectal Dis. 2011; 26: 63544.
  • 83
    Maroo MK, Nag NK, Sortur SV, Patil RS. Ulcerative colitis in Southern Maharashtra. J. Indian Med. Assoc. 1974; 63: 3504.
  • 84
    Park SH, Kim YM, Yang SK. Clinical features and natural history of ulcerative colitis in Korea. Inflamm. Bowel Dis. 2007; 13: 27883.
  • 85
    Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 178594.
  • 86
    Park JB, Yang SK, Byeon JS et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm. Bowel Dis. 2006; 12: 114651.
  • 87
    Pongprasobchai S, Manatsathit S, Leelakusolvong S, Sattawatthamrong Y, Boonyapisit S. Ulcerative colitis in Thailand: a clinical study and long term follow-up. J. Med. Assoc. Thai. 2001; 84: 12818.
  • 88
    Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 3508.
  • 89
    Prideaux L, Kamm MA, De Cruz P et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J. Gastroenterol. Hepatol. 2011; 27: 91927.
  • 90
    Jess T, Riis L, Vind I. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm. Bowel Dis. 2007; 13: 4819.
  • 91
    Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 1991; 324: 848.
  • 92
    Peeters M, Nevens H, Baert F et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111: 597603.
  • 93
    Bayless TM, Tokayer AZ, Polito JM 2nd, Quaskey SA, Mellits ED, Harris ML. Crohn's disease: concordance for site and clinical type in affected family members—potential hereditary influences. Gastroenterology 1996; 111: 5739.
  • 94
    van der Heide F, Dijkstra A, Weersma RK et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 2009; 15: 1199207.
  • 95
    Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 1989; 34: 184154.
  • 96
    Harries AD, Jones L, Heatley RV, Rhodes J. Smoking habits and inflammatory bowel disease: effect on nutrition. Br. Med. J. (Clin Res Ed) 1982; 284: 1161.
  • 97
    Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N. Engl. J. Med. 1987; 316: 70710.
  • 98
    Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am. J. Gastroenterol. 1989; 84: 313.
  • 99
    Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98: 11238.
  • 100
    Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 10939.
  • 101
    Kurata JH. Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J. Clin. Gastroenterol. 1994; 19: 16671.
  • 102
    Jiang L, Xia B, Li J et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J. Clin. Gastroenterol. 2007; 41: 2804.
  • 103
    Jiang XL, Cui HF. An analysis of 10 218 ulcerative colitis cases in China. World J. Gastroenterol. 2002; 8: 15861.
  • 104
    Naganuma M, Iizuka B, Torii A et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am. J. Gastroenterol. 2001; 96: 11236.
    Direct Link:
  • 105
    Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm. Bowel Dis. 2002; 8: 27786.
  • 106
    Frisch M, Pedersen BV, Andersson RE. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ 2009; 338: b716.
  • 107
    Beaugerie L, Sokol H. Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD. Inflamm. Bowel Dis. 2010; 16: 3567.
  • 108
    Kaplan GG, Pedersen BV, Andersson RE. The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut 2007; 56: 138792.
  • 109
    Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 6506.
  • 110
    Tjonneland A, Overvad K, Bergmann MM et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58: 160611.
  • 111
    Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am. J. Gastroenterol. 2010; 105: 2195201.
  • 112
    Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur. J. Clin. Nutr. 1998; 52: 22938.
  • 113
    Jowett SL, Seal CJ, Pearce MS et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 147984.
  • 114
    Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 2011; 106: 56373.
  • 115
    Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am. J. Clin. Nutr. 1996; 63: 7415.
  • 116
    Sakamoto N, Kono S, Wakai K et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm. Bowel Dis. 2005; 11: 15463.
  • 117
    Ng SC, Tsoi KKF, Kamm MA et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm. Bowel Dis. 2011 Sep 1. doi: 10.1002/ibd.21845. [Epub ahead of print].
  • 118
    Leong RW, Armuzzi A, Ahmad T et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment. Pharmacol. Ther. 2003; 17: 146570.
  • 119
    Guo QS, Xia B, Jiang Y, Qu Y, Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol. 2004; 10: 106971.
  • 120
    Li M, Gao X, Guo CC, Wu KC, Zhang X, Hu PJ. OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J. Gastroenterol. 2008; 14: 49237.
  • 121
    Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 2002; 47: 46972.
  • 122
    Inoue N, Tamura K, Kinouchi Y et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 8691.
  • 123
    Croucher PJ, Mascheretti S, Hampe J. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 2003; 11: 616.
  • 124
    Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS. Common NOD2 mutations are absent in patients with Crohn's disease in India. Indian J. Gastroenterol. 2008; 27: 2013.
  • 125
    Chua KH, Hilmi I, Ng CC et al. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J. Dig. Dis. 2009; 10: 12430.
  • 126
    Yamazaki K, Onouchi Y, Takazoe M. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J. Hum. Genet. 2007; 52: 57583.
  • 127
    Yang SK, Park M, Lim J et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm. Bowel Dis. 2009; 15: 138590.
  • 128
    Bin C, Zhirong Z, Xiaoqin W et al. Contribution of rs11465788 in IL23R gene to Crohn's disease susceptibility and phenotype in Chinese population. J. Genet. 2009; 88: 1916.
  • 129
    Yamazaki K, McGovern D, Ragoussis J et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 2005; 14: 3499506.
  • 130
    Yang SK, Lim J, Chang HS et al. Association of TNFSF15 with Crohn's disease in Koreans. Am. J. Gastroenterol. 2008; 103: 143742.
    Direct Link:
  • 131
    Sashio H, Tamura K, Ito R et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 10207.
  • 132
    Song Y, Wu KC, Zhang L et al. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease. Chin. J. Dig. Dis. 2005; 6: 1704.
  • 133
    Cao Q, Zhu Q, Wu ML, Hu WL, Gao M, Si JM. Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms. Chin. Med. J. 2006; 119: 1198203.
  • 134
    Mittal RD, Manchanda PK, Bid HK, Ghoshal UC. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. J. Gastroenterol. Hepatol. 2007; 22: 9204.
  • 135
    Moum B, Ekbom A, Vatn MH, Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am. J. Gastroenterol. 1999; 94: 15649.
    Direct Link:
  • 136
    Henriksen M, Jahnsen J, Lygren I et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm. Bowel Dis. 2006; 12: 54350.
  • 137
    Kochhar R, Mehta SK, Nagi B. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J. Gastroenterol. 1991; 10: 889.
  • 138
    Shiga H, Takagi S, Inoue R et al. What determines the later clinical course of patients who do not undergo colectomy at the first attack? A Japanese cohort study on ulcerative colitis. Digestion 2010; 81: 10412.
  • 139
    Lawrance IC, Murray K, Hall A, Sung JJ, Leong R. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am. J. Gastroenterol. 2004; 99: 218694.
    Direct Link:
  • 140
    Rerknimitr R, Chalapipat O, Kongkam P. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review. J. Med. Assoc. Thai. 2005; 88: S12933.
  • 141
    Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand. J. Gastroenterol. 1997; 32: 13947.
  • 142
    Zheng JJ. Clinical aspects of ulcerative colitis in mainland China. Chin. J. Dig. Dis. 2006; 7: 715.
  • 143
    Langholz E, Munkholm P, Davidsen M. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 311.
  • 144
    Stewenius J, Adnerhill I, Ekelund GR. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis. Colon Rectum 1996; 39: 101925.
  • 145
    Lee JH, Cheon JH, Moon CM et al. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Digestion 2010; 81: 23743.
  • 146
    Jang ES, Lee DH, Kim J et al. Age as a clinical predictor of relapse after induction therapy in ulcerative colitis. Hepatogastroenterology 2009; 56: 13049.
  • 147
    Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120: 1320.
  • 148
    Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31: 32933.
  • 149
    Hiwatashi N, Yao T, Watanabe H. Long-term follow-up study of ulcerative colitis in Japan. J. Gastroenterol. 1995; 30: 1316.
  • 150
    Travis SP, Stange EF, Lemann M et al. European evidence-based consensus on the management of ulcerative colitis: current management. J. Crohns Colitis 2008; 2: 2462.
  • 151
    Dobbins WO 3rd. Dysplasia and malignancy in inflammatory bowel disease. Annu. Rev. Med. 1984; 35: 3348.
  • 152
    Kim BJ, Yang SK, Kim JS et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. J. Gastroenterol. Hepatol. 2009; 24: 66771.
  • 153
    Fujita T, Ando T, Watanabe O et al. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan. Hepatogastroenterology 2010; 57: 48792.
  • 154
    Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 52635.
  • 155
    Venkataraman S, Mohan V, Ramakrishna BS. Risk of colorectal cancer in ulcerative colitis in India. J. Gastroenterol. Hepatol. 2005; 20: 7059.
  • 156
    Hata K, Watanabe T, Kazama S et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br. J. Cancer 2003; 89: 12326.
  • 157
    Gong W, Lv N, Wang B et al. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig. Dis. Sci. 2011; 57: 5037.
  • 158
    Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990–1994: a prospective, nationwide, epidemiological study. Eur. J. Gastroenterol. Hepatol. 2000; 12: 318.
  • 159
    Lapidus A. Crohn's disease in Stockholm county during 1990–2001: an epidemiological update. World J. Gastroenterol. 2006; 12: 7581.
  • 160
    Wolters FL, Russel MG, Sijbrandij J et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006; 55: 112430.
  • 161
    Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am. J. Gastroenterol. 2008; 103: 308293.
    Direct Link:
  • 162
    Hisabe T, Matsui T, Sakurai T et al. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J. Gastroenterol. 2003; 38: 1216.
  • 163
    Leong RW, Lawrance IC, Chow DK et al. Association of intestinal granulomas with smoking, phenotype, and serology in Chinese patients with Crohn's disease. Am. J. Gastroenterol. 2006; 101: 10249.
    Direct Link:
  • 164
    Chow DK, Sung JJ, Wu JC, Tsoi KK, Leong RW, Chan FK. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm. Bowel Dis. 2009; 15: 5517.
  • 165
    Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 77782.
  • 166
    Ferrante M, Henckaerts L, Joossens M et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56: 1394403.
  • 167
    Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010; 139: 114755.
  • 168
    Solberg IC, Vatn MH, Hoie O. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin. Gastroenterol. Hepatol. 2007; 5: 14308.
  • 169
    Sachar DB, Bodian CA, Goldstein ES et al. Is perianal Crohn's disease associated with intestinal fistulization? Am. J. Gastroenterol. 2005; 100: 15479.
    Direct Link:
  • 170
    Cosnes J, Cattan S, Blain A. Long-term evolution of disease behavior of Crohn's disease. Inflamm. Bowel Dis. 2002; 8: 24450.
  • 171
    Yang CH, Ding J, Gao Y, Chen X, Yang ZB, Xiao SD. Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease. J. Dig. Dis. 2011; 12: 99104.
  • 172
    Jeon SJ, Lee KJ, Lee MH, Lim SK, Kang CJ, Kim JH. Rates of early surgery and associated risk factors in Crohn's disease. Korean J. Gastroenterol. 2010; 56: 23641.
  • 173
    Iida M, Yao T, Okada M. Long-term follow-up study of Crohn's disease in Japan. The Research Committee of Inflammatory Bowel Disease in Japan. J. Gastroenterol. 1995; 30: 1719.
  • 174
    Okada M, Sakurai T, Yao T. Clinical course and long-term prognosis of Crohn's disease in Japan. J. Gastroenterol. 1994; 29: 40614.
  • 175
    Morimoto N, Kato J, Kuriyama M et al. Risk factors and indications for first surgery in Crohn's disease patients. Hepatogastroenterology 2007; 54: 201116.
  • 176
    Ye BD, Yang SK, Boo SJ et al. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm. Bowel Dis. 2011; 17: 19016.
  • 177
    Pokharna RK, Kabra PK, Sharma R, Kochar DK. Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J. Gastroenterol. 2004; 23: 8990.
  • 178
    Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 2003; 5: 51217.
  • 179
    Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am. J. Gastroenterol. 2001; 96: 111622.
    Direct Link:
  • 180
    Lakatos L, Pandur T, David G et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J. Gastroenterol. 2003; 9: 23007.
  • 181
    Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31: 30727.
  • 182
    Wang YF, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: east and west differences. J. Dig. Dis. 2007; 8: 1217.
  • 183
    Oshitani N, Iimuro M, Kawashima D. Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography. Hepatogastroenterology 2002; 49: 31721.
  • 184
    Loftus EV Jr. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 2004; 6: 50613.
  • 185
    Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am. J. Gastroenterol. 2007; 102: 10429.
    Direct Link:
  • 186
    Bambha K, Kim WR, Talwalkar J et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 13649.
  • 187
    Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010; 52: 5717.
  • 188
    Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004; 126: 192930.
  • 189
    Kochhar R, Goenka MK, Das K et al. Primary sclerosing cholangitis: an experience from India. J. Gastroenterol. Hepatol. 1996; 11: 42933.
  • 190
    Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of primary sclerosing cholangitis in Singapore. J. Gastroenterol. Hepatol. 2002; 17: 90813.
  • 191
    Zhu Q, Cao Q, Si J-M. Quality of care for patients with inflammatory bowel disease in East China. World J. Gastroenterol. 2008; 14: 61216.
  • 192
    Huang LJ, Zhu Q, Lei M, Cao Q. Current use of immunosuppressive agents in inflammatory bowel disease patients in East China. World J. Gastroenterol. 2009; 15: 30559.
  • 193
    Tajiri H, Tomomasa T, Yoden A et al. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Digestion 2008; 77: 1504.
  • 194
    Cao Q, Zhu Q, Shang Y, Gao M, Si J. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Digestion 2009; 79: 5863.
  • 195
    Kim JH, Cheon JH, Hong SS et al. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study. J. Clin. Gastroenterol. 2010; 44: e2428.
  • 196
    Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J. Gastroenterol. 2003; 38: 7406.
  • 197
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China. J. Dig. Dis. 2008; 9: 848.
  • 198
    Higashi D, Futami K, Egawa Y et al. Infliximab treatment for anal fistula in patients with Crohn's disease. Anticancer Res. 2009; 29: 92733.
  • 199
    Zheng JJ, Zhi P, Wang YM et al. Short-term study of infliximab treatment for Crohn's disease in China. J. Dig. Dis. 2011; 12: 1059.
  • 200
    Uchino M, Ikeuchi H, Bando T et al. Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease. World J. Gastroenterol. 2011; 17: 11749.
  • 201
    Sigurbjornsson FT, Bjarnason I. Leukocytapheresis for the treatment of IBD. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008; 5: 50916.
  • 202
    Probert CS, Jayanthi V, Bhakta P. How necessary is colectomy[quest]. An epidemiological study of the surgical management of ulcerative colitis amongst different ethnic groups in Leicestershire. Eur. J. Gastroenterol. Hepatol. 1993; 5: 1720.
  • 203
    Nguyen GC, Torres EA, Regueiro M et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am. J. Gastroenterol. 2006; 101: 101223.
    Direct Link:
  • 204
    Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009; 137: 495501.
  • 205
    Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 158894.
  • 206
    Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol. 2010; 105: 268791.
  • 207
    Leong RW, Koo JH. Colorectal cancer in inflammatory bowel disease. J. Gastroenterol. Hepatol. 2009; 24: 5035.